Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Expanded autologous mixed cell therapy, ixmyelocel-T (formerly Cardiac Repair Cells (CRCs), Tissue repair cells, Vascular repair cells)
print preview
bookmark
share with colleague
General Information
Company
Aastrom Biosciences Inc.
Description
Autologous cell therapy made from bone marrow containing adult stem and progenitor cells using the Tissue Repair Cell technology
Molecular Target
Mechanism of Action
Cell therapy
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy